Cargando…

Long non-coding RNA cancer susceptibility candidate 2 (CASC2) alleviates the high glucose-induced injury of CIHP-1 cells via regulating miR-9-5p/PPARγ axis in diabetes nephropathy

BACKGROUND: High glucose (HG) induced podocytes injury plays an important role in diabetes nephropathy (DN) development. Long noncoding RNA cancer susceptibility candidate 2 (CASC2) was found to be decreased in serum of DN patients. We aimed to explore the function and possible mechanism of CASC2 in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Feng, Dai, Bo, Ni, Xiquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409641/ https://www.ncbi.nlm.nih.gov/pubmed/32774472 http://dx.doi.org/10.1186/s13098-020-00574-8

Ejemplares similares

Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis
por: Wang, Yufeng, et al.
Publicado: (2017)

Long Non-Coding RNA Cancer Susceptibility Candidate 2a (CASC2a) Is a Marker of Early Recurrence After Radical Cystectomy in Patients with Urothelial Carcinoma of the Bladder
por: Li, Zhen, et al.
Publicado: (2018)

Clinical Significance of Serum lncRNA Cancer Susceptibility Candidate 2 (CASC2) for Chronic Renal Failure in Patients with Type 2 Diabetes
por: Wang, Linxia, et al.
Publicado: (2018)

New Insights into the PPARγ Agonists for the Treatment of Diabetic Nephropathy
por: Jia, Zhanjun, et al.
Publicado: (2014)

Long non-coding RNA CASC2 regulates osteoblasts matrix mineralization
por: Freitas, Jaime, et al.
Publicado: (2023)

Role of the adipose PPARγ-adiponectin axis in susceptibility to stress and depression/anxiety-related behaviors
por: Guo, M, et al.
Publicado: (2017)

Berberine Promotes Apoptosis of Colorectal Cancer via Regulation of the Long Non-Coding RNA (lncRNA) Cancer Susceptibility Candidate 2 (CASC2)/AU-Binding Factor 1 (AUF1)/B-Cell CLL/Lymphoma 2 (Bcl-2) Axis
por: Dai, Wei, et al.
Publicado: (2019)

Cancer Susceptibility Candidate 9 (CASC9): A Novel Targetable Long Noncoding RNA in Cancer Treatment
por: Sharma, Uttam, et al.
Publicado: (2020)

The association between the PPARγ2 Pro12Ala polymorphism and nephropathy susceptibility in type 2 diabetes: a meta-analysis based on 9,176 subjects
por: Wang, Lei, et al.
Publicado: (2013)

The PPARγ2 Pro12Ala variant is protective against progression of nephropathy in people with type 2 diabetes
por: Lapice, Emanuela, et al.
Publicado: (2015)

Long non-coding RNA CASC2 suppresses pancreatic cancer cell growth and progression by regulating the miR-24/MUC6 axis
por: Xu, Da-Fang, et al.
Publicado: (2019)

Long Non-coding RNA CASC15 Promotes Intrahepatic Cholangiocarcinoma Possibly through Inducing PRDX2/PI3K/AKT Axis
por: Zhang, Yuan, et al.
Publicado: (2021)

Lncrna CASC11 aggravates diabetic nephropathy via targeting FoxO1
por: Zhang, Yun, et al.
Publicado: (2023)

Ochratoxin A Induces Steatosis via PPARγ-CD36 Axis
por: Zheng, Qian-Wen, et al.
Publicado: (2021)

Amorfrutins Relieve Neuropathic Pain through the PPARγ/CCL2 Axis in CCI Rats
por: Gao, Pengfei, et al.
Publicado: (2021)

An innovative CASC training redesign – ‘experience of virtual mock CASC exam’
por: Rankin, Jennifer, et al.
Publicado: (2021)

CASC15 polymorphisms are correlated with cervical cancer susceptibility in Chinese women
por: Gao, Ziying, et al.
Publicado: (2020)

miR-429-3p/LPIN1 Axis Promotes Chicken Abdominal Fat Deposition via PPARγ Pathway
por: Chao, Xiaohuan, et al.
Publicado: (2020)

An Erk/Cdk5 axis controls the diabetogenic actions of PPARγ
por: Banks, Alexander S., et al.
Publicado: (2014)

PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis
por: Vella, Veronica, et al.
Publicado: (2017)

Nephropathy 1st inhibits renal fibrosis by activating the PPARγ signaling pathway
por: Mu, Linjie, et al.
Publicado: (2022)

PPAR γ/TLR4/TGF-β1 axis mediates the protection effect of erythropoietin on cyclosporin A-induced chronic nephropathy in rat
por: Liu, Bin, et al.
Publicado: (2020)

Piperine Alleviates Doxorubicin-Induced Cardiotoxicity via Activating PPAR-γ in Mice
por: Yan, Jie, et al.
Publicado: (2019)

CDK5 promotes renal tubulointerstitial fibrosis in diabetic nephropathy via ERK1/2/PPARγ pathway
por: Bai, Xiaoyan, et al.
Publicado: (2016)

PER2-mediated ameloblast differentiation via PPARγ/AKT1/β-catenin axis
por: Huang, Wushuang, et al.
Publicado: (2021)

Rosiglitazone Alleviates Mechanical Allodynia of Rats with Bone Cancer Pain through the Activation of PPAR-γ to Inhibit the NF-κB/NLRP3 Inflammatory Axis in Spinal Cord Neurons
por: Fu, Jie, et al.
Publicado: (2021)

Nephropathy in Pparg-null mice highlights PPARγ systemic activities in metabolism and in the immune system
por: Toffoli, Barbara, et al.
Publicado: (2017)

Treatment with a PPAR-γ Agonist Protects Against Hyperuricemic Nephropathy in a Rat Model
por: Wang, Xin, et al.
Publicado: (2020)

Long non-coding RNA CASC2 enhances berberine-induced cytotoxicity in colorectal cancer cells by silencing BCL2
por: Dai, Wei, et al.
Publicado: (2019)

Erythropoietin alleviates hepatic insulin resistance via PPARγ-dependent AKT activation
por: Ge, Zhijuan, et al.
Publicado: (2015)

PPARγ2 Pro12Ala Polymorphism is Associated in Children With Traits Related to Susceptibility to Type 2 Diabetes
por: Vales-Villamarín, Claudia, et al.
Publicado: (2021)

lncRNA CASC2 downregulation participates in rheumatoid arthritis, and CASC2 overexpression promotes the apoptosis of fibroblast-like synoviocytes by downregulating IL-17
por: Liu, Cheng, et al.
Publicado: (2020)

PPARγ in Neuroblastoma
por: Peri, Alessandro, et al.
Publicado: (2008)

Long non-coding RNA CASC15 is upregulated in hepatocellular carcinoma and facilitates hepatocarcinogenesis
por: He, Tianyu, et al.
Publicado: (2017)

A national CASC course
por: Ramesh, Yathooshan, et al.
Publicado: (2021)

Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
por: Kulkarni, Ajit A., et al.
Publicado: (2012)

Molecular Characterization of the Tumor Suppressor Candidate 5 Gene: Regulation by PPARγ and Identification of TUSC5 Coding Variants in Lean and Obese Humans
por: Knotts, Trina A., et al.
Publicado: (2009)

The Impact of PPARγ Genetic Variants on IBD Susceptibility and IBD Disease Course
por: Mwinyi, Jessica, et al.
Publicado: (2012)

Significance of LncRNA CASC8 genetic polymorphisms on the tuberculosis susceptibility in Chinese population
por: Liu, Guoye, et al.
Publicado: (2020)

PPAR-γ Agonist Alleviates Liver and Spleen Pathology via Inducing Treg Cells during Schistosoma japonicum Infection
por: Zhu, Yuxiao, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8pai3rbcdiis7dodp9ke55rfhm